Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
28.37
0.07 (0.25%)
At close: Jun 16, 2025, 3:59 PM
28.41
0.14%
After-hours: Jun 16, 2025, 04:20 PM EDT
0.25% (1D)
| Bid | 26.93 |
| Market Cap | 2.07B |
| Revenue (ttm) | 481.17M |
| Net Income (ttm) | -16.95M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -118.21 |
| Forward PE | 22.28 |
| Analyst | Buy |
| Ask | 28.99 |
| Volume | 555,472 |
| Avg. Volume (20D) | 644,355 |
| Open | 28.06 |
| Previous Close | 28.30 |
| Day's Range | 27.70 - 28.68 |
| 52-Week Range | 17.38 - 30.69 |
| Beta | 0.05 |
About KNSA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KNSA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KNSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+20.54%
Kiniksa Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
7 months ago
-15.66%
Kiniksa Pharmaceuticals shares are trading lower after the company announced worse-than-expected Q3 financial results.
22 hours ago · seekingalpha.com
Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing FastKiniksa Pharmaceuticals has delivered strong share price performance this year thanks to a strong start to the year for Arcalyst. Medicare redesign with improved patient affordability has boosted Arca...
